Form 4 Filing for Jin David at Fortress Biotech, Inc.

David Jin, Chief Financial Officer of Fortress Biotech, Inc., acquired 400,000 restricted stock units on June 22, 2026. These units represent a contingent right to receive one share of common stock each and vest in four equal annual installments starting January 5, 2027, contingent upon continued service. The acquisition was made at a price of $0.0 per unit. Following this transaction, Jin David holds a total of 1,651,571 shares. This total includes 1,230,000 shares underlying previously granted deferred restricted stock units. The filing is an ordinary business operation.